key: cord-1036575-c6w4m2ah authors: Antonelli, Maria; Kushner, Irving title: Low Serum Levels of 25-hydroxyvitamin D Accompany Severe COVID-19 Because it is a Negative Acute Phase Reactant date: 2021-06-22 journal: Am J Med Sci DOI: 10.1016/j.amjms.2021.06.005 sha: 7267d4c04afd126fdd91f011d010e39be378918a doc_id: 1036575 cord_uid: c6w4m2ah nan A large number of systemic changes accompany inflammation -the acute phase response. Inflammation, one of the first responses of the activated innate immune system, has long been defined as the response to infection and tissue injury. Its presence was classically recognized by the presence of heat, swelling, redness, and pain. Inflammation is triggered by receptors which recognize pathogen-associated molecular patterns (PAMPs) in the case of microorganism-induced inflammation, and by damage-associated molecular patterns (DAMPs) in the case of tissue injury. Initial studies of the acute phase response followed on the discovery in 1930 of marked increases in concentration of C-reactive protein (CRP) in the serum of patients during the acute phase of pneumococcal pneumonia and other infectious diseases. Positive acute phase reactants are molecules whose plasma concentrations rise during the acute phase response; examples include CRP, serum amyloid A, and fibrinogen. Negative acute phase reactants, whose serum concentrations fall during inflammatory states, include albumin, transferrin, zinc, and iron, among others. 4 In the 21 st century, however, our understanding of what can elicit inflammation has expanded considerably. We have learned that the innate immune system responds to metabolic stress with chronic low-grade inflammation -"metaflammation" -without the classic signs of acute inflammation. This has led to a redefinition of inflammation as the innate immune response to harmful stimuli such as pathogens, injury and metabolic stress. 5 Low-grade inflammation is accompanied by a modest acute phase response, including a minor degree of CRP elevation, commonly characterized today as systemic inflammation. Just beginning to be investigated are the harmful metabolic stimuli that can trigger inflammatory responses -via metabolismassociated molecular patterns (MAMPs) and NLRP3. Low-grade inflammation, as manifested by minor CRP elevation, is associated with an astounding number of conditions and lifestyles associated with poor health, and which represent or reflect metabolic stresses. Examples include diabetes mellitus, obesity, hypertension, atrial fibrillation, obstructive sleep apnea, excessive nutrient consumption, poor sleep, the Western lifestyle, and a large variety of unhealthy diets. The conclusion that 25[OH]D is a negative acute phase reactant is now supported by three independent lines of evidence. Effect of a Single High Dose of Vitamin D 3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial Does serum 25-hydroxyvitamin D decrease during acute-phase response? A systematic review Vitamin D: a negative acute phase reactant Acute-phase proteins and other systemic responses to inflammation It's time to redefine inflammation Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey Associations of C-reactive Protein with 25-hydroxyvitamin D in 24 Specific Diseases: A Cross-sectional Study from NHANES The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention Vitamin D in systemic and organ specific autoimmune diseases The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion Hypovitaminosis D in bariatric surgery: A systematic review of observational studies Vitamin D deficiency and co-morbidities in COVID-19 patients -A fatal relationship? Distribution of C-reactive protein values in the United States The authors have no potential conflicts of interest and all authors have read the journal's policy on disclosure of potential conflicts of interest. Both authors have read the journal's authorship agreement and the manuscript has been reviewed by and approved by all named authors. We are grateful to Drs. Nathan Berger and Stan Ballou for their very helpful input. There was no financial support for this manuscript.